Baebies Overview

Baebies (testing platform for newborn health screening)

Baebies focuses on advancing newborn screening and other pediatric testing worldwide.

Baebies was founded in 2014 by Richard West and Vamsee Pamula, following the successful development of digital microfluidics technology, the development and launch of multiple products, and the eventual sale of Advanced Liquid Logic to Illumina, Inc. Baebies has now licensed its core technology, acquired product and manufacturing assets, and built a seasoned management and technical team to pursue opportunities in newborn screening and pediatric testing.

Category: Medical Device

Founded Date: 2013

Founders: Richard West & Vamsee Pamula



Number of Funding Rounds: 6

Total Funding Amount: $36.3

Series B: $5,000,000

Series B: $5,000,000

Series A - Unknown   

Venture - Series Unknown: $12,761,733

Debt Financing: $500,000


Baebies is developing innovative solutions for biochemical testing built on digital microfluidics and other technology.

Baebies is guided by a vision that every newborn deserves a healthy start, irrespective of the socio-economic status and geographic location. Baebies is on a mission to save lives and make lives better for millions of babies by bringing new technolog ies, new tests, and new hope for parents and healthcare professionals worldwide.

Charlotte Angel Fund has a unique blend of talent to dig in deep for due diligence and to be helpful no matter what the challenge. They have been a joy to work with!
— — Richard M. West (Founder & CEO @ Baebies)